首页> Arthritis & rheumatology.> An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity

导出原文传递

翻译打印收藏纠错

第一作者： Tran‐Duy An

作者： Tran‐Duy An ^[1] ; Ghiti Moghadam Marjan ^[2] ; Oude Voshaar Martijn A. H. ^[3] ; Vonkeman Harald E. ^[4] ; Boonen Annelies ^[5] ; Clarke Philip ^[6] ; McColl Geoff ^[7] ; Klooster Peter M. ^[8] ; Zijlstra T. R. ^[9] ; Lems Willem F. ^[10] ; Riyazi N. ^[11] ; Griep E. N. ^[12] ; Hazes J. M. W. ; Landewé Robert ; Bernelot Moens Hein J. ; Riel Piet L. C. M. ; Laar Mart A. F. J. ; Jansen T. L. ; the Dutch National POET Collaboration

作者单位： VU University Medical Center and Reade Medical CenterAmsterdam,The Netherlands ^[1] Viecurie Medical CenterVenlo,The Netherlands ^[2] Arthritis Center TwenteMedisch Spectrum TwenteEnschede,The Netherlands ^[3] Erasmus University Medical CenterRotterdam,The Netherlands ^[4] AMC AmsterdamAmsterdam,The Netherlands ^[5] Maastricht University Medical Center and Maastricht UniversityMaastricht,The Netherlands ^[6] Ziekenhuisgroep TwenteAlmelo and Hengelo,The Netherlands ^[7] Radboud University Medical CenterNijmegen,The Netherlands ^[8] Isala Medical CenterZwolle,The Netherlands ^[9] Haga Medical CenterThe Hague,The Netherlands ^[10] Antonius Medical CenterSneek,The Netherlands ^[11] University of MelbourneMelbourne,Victoria,Australia ^[12]

发布时间 2018-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交